Literature DB >> 20016286

The POPX2 phosphatase regulates cancer cell motility and invasiveness.

Agatha Susila1, Hei Chan, Andrew Xiong-Wen Loh, Hui-Qun Phang, Ee Tsin Wong, Vinay Tergaonkar, Cheng-Gee Koh.   

Abstract

Rho GTP ases play major roles in the regulation of actin cytoskeleton, cell movement and cell cycle. PAK, one of the effector kinases of these small GTP ases, has long been associated with different types of cancer. Therefore, it is likely that deregulation of PAK activity or expression may contribute to the development of cancer. POP X2, a PP 2C serine/threonine phosphatase, is known to dephosphorylate PAK and downregulate its activity. We find that POPX2 is expressed in a wide variety of tumour cell lines, the levels being highest in the more invasive MDA-MB-231 and lowest in the non-invasive MCF7 breast cancer lines. We show that silencing of POPX2 reduces the amount of stress fibers and focal adhesions in both cells lines. Interestingly, POPX2 deficiency dramatically reduces cell motility and invasiveness in MDA-MB-231 cells, and cell motility in MCF7 cells. Conversely, overexpression of POP X2 in MDA-MB-231 and MCF7 cells increased their motility. The silencing of POP X2 also inhibits the expression of beta1 integrin implying that POP X2 may modulate cell attachment to the extra-cellular matrix, as reflected in diminished initial colonization of POPX2 knockdown cells in nude mice. Based on these results, we propose a mechanism by which POP X2 regulates the invasive behavior of the cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20016286     DOI: 10.4161/cc.9.1.10406

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  16 in total

1.  MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F.

Authors:  Sarah Jurmeister; Marek Baumann; Aleksandra Balwierz; Ioanna Keklikoglou; Aoife Ward; Stefan Uhlmann; Jitao David Zhang; Stefan Wiemann; Özgür Sahin
Journal:  Mol Cell Biol       Date:  2011-12-05       Impact factor: 4.272

2.  POPX2 phosphatase regulates cell polarity and centrosome placement.

Authors:  Jing-Ling Hoon; Hoi-Yeung Li; Cheng-Gee Koh
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

3.  Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins.

Authors:  Jana Mladkova; Miloslav Sanda; Eva Matouskova; Irena Selicharova
Journal:  BMC Cancer       Date:  2010-08-23       Impact factor: 4.430

4.  Loss of PPM1F expression predicts tumour recurrence and is negatively regulated by miR-590-3p in gastric cancer.

Authors:  Jing Zhang; Ming Jin; Xiaoyu Chen; Rui Zhang; Yanxia Huang; Hui Liu; Jinshui Zhu
Journal:  Cell Prolif       Date:  2018-02-22       Impact factor: 6.831

5.  PPM1F in Dentate Gyrus Modulates Anxiety-Related Behaviors by Regulating BDNF Expression via AKT/JNK/p-H3S10 Pathway.

Authors:  Fantao Meng; Jing Liu; Juanjuan Dai; Haifeng Lian; Shujun Jiang; Qiongyu Li; Min Wu; Wentao Wang; Dan Wang; Di Zhao; Cuilan Liu; Changyun Qiu; Chen Li
Journal:  Mol Neurobiol       Date:  2021-03-21       Impact factor: 5.590

6.  Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia.

Authors:  Marieke H van der Linden; Lidija Seslija; Pauline Schneider; Emma M C Driessen; Patricia Garrido Castro; Dominique J P M Stumpel; Eddy van Roon; Jasper de Boer; Owen Williams; Rob Pieters; Ronald W Stam
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

7.  Protein phosphatase Mg2+/Mn2+ dependent 1F promotes smoking-induced breast cancer by inactivating phosphorylated-p53-induced signals.

Authors:  Shih-Hsin Tu; Yin-Ching Lin; Chi-Cheng Huang; Po-Sheng Yang; Hui-Wen Chang; Chien-Hsi Chang; Chih-Hsiung Wu; Li-Ching Chen; Yuan-Soon Ho
Journal:  Oncotarget       Date:  2016-11-22

Review 8.  Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Richard A Franklin; Giuseppe Montalto; Melchiorre Cervello; Massimo Libra; Saverio Candido; Grazia Malaponte; Maria C Mazzarino; Paolo Fagone; Ferdinando Nicoletti; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Francesca Chiarini; Camilla Evangelisti; Lucio Cocco; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-10

9.  miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.

Authors:  Gang Luo; Ya-Ling Chao; Bo Tang; Bo-Sheng Li; Yu-Feng Xiao; Rui Xie; Shu-Ming Wang; Yu-Yun Wu; Hui Dong; Xiang D Liu; Shi-Ming Yang
Journal:  Oncotarget       Date:  2015-11-10

10.  Digoxin enhances radiation response in radioresistant A549 cells by reducing protein phosphatase 2A.

Authors:  Ji Young Lee; Mi-Sook Kim; Mi So Lee; Jae Eun Ju; Namhyun Chung; Youn Kyoung Jeong
Journal:  Biosci Rep       Date:  2017-11-29       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.